EUVIMEDEUVIMED entdecken
Crossref

Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer

Xuan Xie, Jiahao Zhou, Qingbin Wu, Jing Sun, Chi Shu, Jun Huang, Changtao Li, Xin Wang, Xia Shen, Xue Li, Zhipeng Luo, Chuan Xu iD und 2 weitere

Carcinogenesis · 2025

DOI: 10.1093/carcin/bgag001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Xuan Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Proteomics, Blood Proteins. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasma proteins have been reported as predictors and potential targets for reducing colorectal cancer (CRC) risk. However, their potential roles in CRC prognosis remain unexplored. We measured plasma levels of 367 neuro-related proteins in CRC patients from the West China Hospital (WCH) cohort (N = 150, median follow-up = 46.72 months) via proximity extension assay. The least absolute shrinkage and selection operator penalized Cox regression identified five overall survival (OS)—and eleven disease-free survival—associated proteins, and the multiprotein signature for OS prediction was then validated in the UK Biobank (UKB) cohort (N = 1133). To overcome possible effects from confounders, we then employed Mendelian randomization analysis leveraging protein quantitative trait loci to investigate associations between genetically determined protein concentration and OS and cancer-specific survival of CRC in the UKB. We found that multiprotein signature developed in the WCH cohort (c-index = 0.784, 95% CI = 0.713–0.855) showed significant discriminative ability in the external UKB cohort (c-index = 0.616, 95% CI = 0.559–0.673). A significant association between genetically determined PD-L1 and OS (P = 0.043, HR = 1.53, 95% CI = 1.01–2.29) was observed, although we did not find strong evidence for colocalization. Additionally, single-cell and spatial transcriptome analyses illustrated PD-L1 expression localized predominantly to epithelial cells and immune cells (especially myeloid cells) in CRC tissue. The potential interactions of identified proteins were evaluated in the STRING database. Druggability evaluation also supported PD-L1 as a potential therapeutic target for CRC. Taken together, this study established multiprotein signatures for CRC prognosis and identified plasma PD-L1 as a possible biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorProteomicsBlood ProteinsHumansPrognosisFemaleMaleMiddle AgedAgedQuantitative Trait LociMendelian Randomization Analysis

Stichwörter der Autor:innen

Mendelian randomizationcolorectal cancerplasma proteinprognostic modelsurvival outcome

Substanzen

Biomarkers, TumorBlood Proteins

Autor:innen und Institutionen

  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China.
  • Yu-Yue Pathology Scientific Research Center, Jinfeng Laboratory, Chongqing 400039, China.
  • Colorectal Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu 610041, China.
  • Department of Big Data in Health Science School of Public Health, Center of Clinical Big Data and Analytics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Division of Vascular Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Guangzhou 511462, China.

ORCID-Profile: Chuan Xu, Ziqiang Wang, Yazhou He

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Xie, X., Zhou, J., Wu, Q., Sun, J., Shu, C., Huang, J., Li, C., Wang, X., Shen, X., Li, X., Luo, Z., Xu, C., Wang, Z., & He, Y. (2025). Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer. Carcinogenesis. https://doi.org/10.1093/carcin/bgag001

Vancouver

Xie X, Zhou J, Wu Q, Sun J, Shu C, Huang J, et al. Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer. Carcinogenesis. 2025. doi:10.1093/carcin/bgag001

BibTeX
@article{Xie2025,
  author = {Xie, Xuan and Zhou, Jiahao and Wu, Qingbin and Sun, Jing and Shu, Chi and Huang, Jun and Li, Changtao and Wang, Xin and Shen, Xia and Li, Xue and Luo, Zhipeng and Xu, Chuan and Wang, Ziqiang and He, Yazhou},
  title = {Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer},
  journal = {Carcinogenesis},
  year = {2025},
  doi = {10.1093/carcin/bgag001}
}
Kostenlos starten →